Synthorx to Present at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
15 mai 2019 17h15 HE
|
Synthorx, Inc.
SAN DIEGO, May 15, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company discovering and developing optimized biologics for cancer and autoimmune disorders, today announced...
Synthorx Reports First Quarter Financial Results
30 avr. 2019 16h05 HE
|
Synthorx, Inc.
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx to Present at H.C. Wainwright Global Life Sciences Conference in London
02 avr. 2019 08h00 HE
|
Synthorx, Inc.
SAN DIEGO, April 02, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx to Present at the American Association of Cancer Research (AACR) Annual Meeting 2019
19 mars 2019 08h00 HE
|
Synthorx, Inc.
SAN DIEGO, March 19, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx Reports Fourth Quarter and Full Year 2018 Financial Results
12 mars 2019 16h05 HE
|
Synthorx, Inc.
Company Positioned for Upcoming 2019 Milestones After Successful IPO Raising $150.7 Million in Gross Proceeds Presented Preclinical Safety and Anti-Tumor Data on Lead Product Candidate THOR-707 at...
Synthorx to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
12 mars 2019 08h00 HE
|
Synthorx, Inc.
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx to Present at the 8th Annual SVB Leerink Global Healthcare Conference
21 févr. 2019 16h05 HE
|
Synthorx, Inc.
SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx Appoints Andrew Powell, J.D., to its Board of Directors
20 déc. 2018 08h00 HE
|
Synthorx, Inc.
SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
12 déc. 2018 16h05 HE
|
Synthorx, Inc.
SAN DIEGO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...
Synthorx Announces Pricing of Initial Public Offering
06 déc. 2018 21h15 HE
|
Synthorx, Inc.
SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop...